The Definitive Guide to Medical Necessity Criteria for ADHD Therapy Insurance Coverage
If you've ever had an ADHD therapy claim denied — or spent 45 minutes on a peer-to-peer review call defending a treatment plan that felt obvious — you already know the frustration. Insurance payers don't just want to know that your client has ADHD. They want documented proof that the therapy you're providing is medically necessary, clinically appropriate, and tied to measurable functional impairment.
This guide breaks down exactly what that looks like in practice: the criteria payers use, the documentation they scrutinize, the CPT codes most commonly flagged, and how to build a defensible record that survives audits and pre-authorization reviews. Whether you're an LPC, LCSW, LMFT, or psychiatrist, this is the clinical and billing information you need to stop leaving reimbursements on the table.
What "Medical Necessity" Actually Means for ADHD Therapy
Medical necessity is the gatekeeper for insurance reimbursement. Every major commercial payer — Aetna, UnitedHealthcare (Optum), Cigna, Anthem/Elevance, and Blue Cross Blue Shield — uses some variation of this definition:
"Services are medically necessary when they are required to diagnose or treat an illness, injury, or condition; are consistent with the diagnosis and accepted standards of care; are not primarily for the convenience of the patient or provider; and are provided in the most appropriate, cost-effective setting."
For ADHD specifically, that definition creates a documentation burden that trips up even experienced clinicians. Why? Because ADHD is commonly perceived — especially by claims reviewers — as a "management condition" rather than one requiring ongoing psychotherapy. You have to consistently demonstrate that therapy is doing something that medication alone cannot.
The three pillars of medical necessity for ADHD therapy are:
- Diagnosis with documented functional impairment (not just symptoms)
- A treatment plan with measurable, time-bound goals
- Ongoing clinical progress notes that reflect active treatment, not just support
Let's go deep on each.
Pillar 1: Diagnosis + Functional Impairment Documentation
A DSM-5-TR diagnosis of ADHD (F90.0 – Predominantly Inattentive, F90.1 – Predominantly Hyperactive-Impulsive, or F90.2 – Combined Presentation) is necessary but not sufficient. Payers want to see the impact of that diagnosis on the client's daily functioning.
This means your intake documentation and treatment plan should explicitly address how ADHD symptoms are impairing the client across multiple domains. The more specific, the better.
Domains to document:
- Occupational/Academic functioning: Missed deadlines, poor performance reviews, job loss, academic probation, incomplete coursework
- Interpersonal relationships: Conflict with partners or family members due to forgetfulness or impulsivity, social isolation
- Daily living: Chronic disorganization, inability to manage finances, missed appointments, poor hygiene routines
- Safety: Impulsive decision-making that creates risk (reckless driving, financial impulsivity, substance use)
- Emotional dysregulation: Rejection-sensitive dysphoria (RSD), mood lability, low frustration tolerance
Pro tip: Use standardized rating scales and document the scores in the chart. The Conners Adult ADHD Rating Scale (CAARS), the Adult ADHD Self-Report Scale (ASRS), and the Vanderbilt Assessment Scale (for pediatric clients) create objective, quantifiable evidence of impairment. Payers love numbers. "Client scored 72 on the CAARS Inattention subscale, indicating clinically significant impairment" is infinitely more defensible than "client reports difficulty focusing."
Pillar 2: Treatment Plan Requirements by Payer
Your treatment plan is the backbone of your medical necessity argument. It has to be individualized, clinically justified, and time-stamped. Reviewing payer-specific requirements will save you enormous headache.
| Payer | Treatment Plan Review Frequency | Specific ADHD Requirements | Notable Quirks | |---|---|---|---| | UnitedHealthcare / Optum | Every 90 days (outpatient) | Requires evidence-based modality (CBT, DBT-informed) listed | Known for requesting peer-to-peer reviews on ADHD cases after 20+ sessions | | Aetna | Every 60–90 days | Goals must be measurable and tied to GAF/WHODAS scores | Will sometimes require neuropsychological testing documentation | | Cigna / Evernorth | Every 90 days | Functional impairment scale required (PHQ-9, ASRS, or equivalent) | Scrutinizes cases where medication has been prescribed — want proof therapy adds value | | Anthem / Elevance | Every 60 days | Separate goals for medication management vs. therapy if applicable | Stringent on "least restrictive level of care" language | | BCBS (varies by state) | Every 90 days | Progress toward goals must be documented quantitatively | Some state plans require pre-auth after session 8 for ADHD | | Medicaid (varies by state) | Every 30–90 days | Often requires co-occurring diagnosis documentation | Very focused on functional impairment + safety risk |
What your treatment plan must include (non-negotiable):
- DSM-5-TR diagnosis with specifiers (e.g., F90.2 – Combined Presentation, Moderate)
- A clear problem list tied to the ADHD diagnosis
- Measurable, behavioral goals with target dates (e.g., "Client will use the Pomodoro technique daily and report ≥4/7 days of implementation within 60 days")
- Identified evidence-based treatment modality — CBT for ADHD, Cognitive Remediation, DBT-informed skills training, or ADHD coaching components within therapy
- Estimated duration of treatment and frequency of sessions
- Coordination of care notes if a prescriber is involved
Pillar 3: Progress Notes That Actually Prove Medical Necessity
This is where most claims fall apart. A progress note that reads "Client discussed difficulties at work. Provided supportive listening. Plan: continue therapy" is a red flag for any reviewer — and it will not hold up in an audit.
Your session notes need to make a reviewer who has never met your client understand:
- What symptoms/functional impairments were present this session
- What specific intervention you used (and why)
- How the client responded
- What progress or lack of progress is evident compared to the treatment plan goals
- What the clinical justification is for continuing at the current frequency
ADHD-specific interventions to document by name:
- Cognitive Behavioral Therapy for ADHD (CBT-ADHD, Safren protocol)
- Executive Function Coaching within therapy
- Emotional Regulation skills training (identify RSD episodes, worked on grounding)
- Behavioral activation and scheduling strategies
- Motivational Interviewing for medication adherence
- Parent Training / Behavioral Parent Training (BPT) for pediatric cases
- Social Skills Training (SST) for pediatric/adolescent clients
Sample note language that supports medical necessity:
"This 45-minute individual psychotherapy session (CPT 90837) focused on executive dysfunction impairing the client's occupational functioning. Client reported three missed project deadlines this week, consistent with ADHD-related working memory deficits (F90.2). Therapist introduced and practiced the 'body double' technique and time-blocking using a visual timer. Client demonstrated moderate engagement and was able to complete a sample 2-hour work block with therapist coaching. Homework assigned: implement technique on Tuesday and Thursday. This session aligns with Treatment Plan Goal #2 (improve task initiation and completion rates to ≥70% by 12/31/2025). Medical necessity maintained given ongoing functional impairment and active skill acquisition phase."
That note is defensible. It has a diagnosis, a specific intervention, a goal reference, and a clinical rationale for continued treatment.
CPT Codes Most Commonly Used for ADHD Therapy (and Audit Risks)
| CPT Code | Description | Typical Duration | ADHD-Specific Audit Risk | |---|---|---|---| | 90837 | Individual psychotherapy | 53+ minutes | High — frequently reviewed for medical necessity at 20+ sessions | | 90834 | Individual psychotherapy | 45 minutes | Medium | | 90832 | Individual psychotherapy | 30 minutes | Low — but watch for downcoding pressure | | 90847 | Family therapy with patient | 50+ minutes | Medium — document parent's involvement in ADHD management | | 90846 | Family therapy without patient | 50+ minutes | Medium — justify why patient not present | | 96130–96133 | Psychological testing | Variable | Low audit risk but requires testing justification | | 99213–99215 | E/M codes (psychiatry) | Variable | High for ADHD med management — document medical decision-making | | H2019 | Therapeutic behavioral services | Per 15 min | Medicaid-specific; used for intensive behavioral support |
Important: If you're billing 90837 (the highest-value individual therapy code) for ADHD clients long-term, make sure your notes clearly justify the 53+ minute session. Payers — especially Optum — have algorithms that flag high-frequency use of 90837 for ADHD clients where no co-occurring diagnosis is documented. A co-occurring diagnosis of Anxiety (F41.1), Depression (F32.x), or Adjustment Disorder (F43.2x) alongside ADHD significantly strengthens your medical necessity argument and is clinically accurate for a large majority of ADHD clients.
Pre-Authorization for ADHD Therapy: What to Expect
Pre-authorization requirements for ADHD therapy vary widely:
- Aetna and Cigna often require pre-auth starting at session 7–8 for outpatient therapy, especially for minors
- UnitedHealthcare typically allows 8–10 sessions before triggering a concurrent review
- Medicaid managed care plans are the most variable — some require auth at session 1, others give you 20 sessions before review
- BCBS state plans vary dramatically; always verify with the specific plan
When submitting a pre-auth for ADHD therapy, include:
- Completed intake/biopsychosocial assessment
- DSM-5-TR diagnosis with severity specifier
- Standardized assessment scores (ASRS, Conners, Vanderbilt)
- Initial treatment plan with measurable goals
- Statement of evidence-based modality
- Any prior treatment history (medication trials, previous therapy)
- Documentation of functional impairment in at least two life domains
Common Reasons ADHD Therapy Claims Get Denied (And How to Fix Them)
Understanding denial patterns saves you thousands in lost revenue annually.
1. "Not medically necessary" — Denial Code CO-50 Fix: Strengthen your treatment plan and progress notes with functional impairment language and specific intervention descriptions. File a clinical appeal with session notes attached.
2. "Experimental or investigational" — Denial Code CO-49 Fix: This is rare for ADHD therapy but can happen with newer modalities. Cite the APA Clinical Practice Guidelines and peer-reviewed literature (CBT-ADHD is well-established).
3. "Exceeds frequency guidelines" Fix: Document clinical justification for weekly vs. biweekly frequency. A client with severe functional impairment and no medication stability has a much stronger case for weekly sessions.
4. "Diagnosis not covered" or "Diagnosis mismatch" Fix: Ensure your billing diagnosis code matches exactly what's in the clinical record. Never bill a different code than what's documented — that's fraud risk. If ADHD is comorbid with anxiety or depression, consider which diagnosis is driving treatment.
5. "Lack of treatment plan on file" Fix: Ensure your EHR or documentation system stores treatment plans and that they're updated per payer requirements. Expired treatment plans are one of the top audit triggers.
Documentation Audit Defense: What ADHD Therapy Records Must Have
If you receive a request for records from a payer (a "medical records request" or "ADR"), here's what needs to be in that file:
- ✅ Signed intake/consent forms
- ✅ Biopsychosocial assessment with ADHD-specific history
- ✅ DSM-5-TR diagnostic formulation with specifiers
- ✅ Standardized rating scale scores with dates
- ✅ Signed, dated treatment plan (updated per payer schedule)
- ✅ Progress notes for every billed session (not generic templates)
- ✅ Treatment plan reviews/updates with clinical rationale
- ✅ Coordination of care documentation if working with a prescriber
- ✅ Discharge planning or transition notes if applicable
Missing even two or three of these can result in recoupment demands — where the payer demands back payment for already-reimbursed sessions. These recoupments can run into the tens of thousands of dollars for group practices.
FAQ: Medical Necessity for ADHD Therapy
Q1: Does my client need an official ADHD diagnosis before I can bill insurance for therapy?
Yes — for the claim to be medically necessary under most payer guidelines, a DSM-5-TR diagnosis must be documented. However, you don't need neuropsychological testing unless the payer specifically requires it. A clinical diagnosis based on DSM-5-TR criteria, history, and standardized rating scales is generally sufficient. If you're still in assessment phase, billing under a "rule-out" or "unspecified" code (e.g., F90.9) while completing the diagnostic workup is acceptable — just document that you're in a diagnostic phase.
Q2: My client is already on ADHD medication. Do I still need to justify therapy as medically necessary?
Absolutely, and this is one of the most important points in this guide. Payers — especially Cigna and UnitedHealthcare — will flag cases where a client is on stimulant medication and still receiving weekly therapy long-term. You must explicitly document what therapy is addressing that medication cannot: executive function skill-building, emotional regulation, relationship repair, organizational systems, self-esteem, and cognitive restructuring around ADHD identity. Make that case in every treatment plan and every concurrent review submission.
Q3: Can I bill for parent sessions (without the child present) as medically necessary for pediatric ADHD cases?
Yes, CPT 90846 (family therapy without patient) is appropriate when you're conducting Behavioral Parent Training (BPT) — which has strong evidence for pediatric ADHD (Barkley, 2013; AAP guidelines). Document that the parent session directly serves the identified patient's treatment goals and ties to the child's treatment plan. Many payers will cover this; just make sure the child is the identified patient on the claim.
Q4: How often do I need to update my treatment plan for ADHD therapy to maintain medical necessity?
It depends on the payer, but a safe standard is every 60–90 days, or whenever there is a significant clinical change. Document the review date, any updated goals, and a clear rationale for continued treatment frequency and modality. Optum's behavioral health guidelines, for example, explicitly state that treatment plans must reflect "active, goal-directed treatment" — not maintenance or supportive care — to qualify as medically necessary.
Q5: What happens if I get a concurrent review request for an ADHD therapy case? What do payers look for?
Concurrent reviews (ongoing authorization reviews) are essentially a payer asking "should we keep approving this?" They'll review your progress notes and treatment plan for: (a) measurable progress toward goals OR a clinical explanation for why progress is slow, (b) evidence that treatment is active rather than supportive, (c) continued functional impairment that justifies ongoing treatment, and (d) a plan for termination or step-down. The worst thing you can do is submit templated, copy-paste notes. Reviewers catch those immediately, and it's one of the fastest routes to a denial.
Q6: Can I use telehealth sessions for ADHD therapy and still meet medical necessity criteria?
Yes. Since the COVID-19 public health emergency expanded telehealth coverage, most major commercial payers and Medicaid plans continue to cover telehealth behavioral health services at parity with in-person sessions. Bill the same CPT codes with the appropriate telehealth modifier (95 for live audio-video, or GT for Medicare). The medical necessity documentation requirements are identical — telehealth is a modality, not a different clinical standard.
How Mozu Health Helps You Stay Compliant and Get Paid
If reading this guide gave you a mild anxiety response about your current documentation, you're not alone. Most therapists and psychiatrists are undertrained on payer-specific medical necessity standards — and that gap costs private practices an average of $30,000–$50,000 per year in denied or underpaid claims.
That's where Mozu Health comes in.
Mozu Health is an AI-powered clinical documentation platform built specifically for behavioral health providers — therapists, psychiatrists, LPCs, LCSWs, LMFTs, and group practices. Here's what it does for ADHD therapy documentation specifically:
- AI-assisted progress notes that automatically incorporate DSM-5-TR diagnostic language, functional impairment documentation, and named interventions — so every note is audit-ready
- Treatment plan templates pre-built for ADHD with measurable, payer-aligned goals and automatic review reminders
- Billing accuracy checks that flag documentation gaps before you submit a claim (missing diagnosis specifiers, expired treatment plans, mismatched CPT codes)
- Audit defense tools that compile complete clinical records in payer-ready format with a single click
- HIPAA-compliant infrastructure so your client data is always protected
Whether you're a solo practitioner managing 40 clients or a group practice with 20 clinicians, Mozu Health makes the documentation side of ADHD therapy faster, smarter, and financially safer.
Ready to stop losing money to documentation gaps and claim denials?
👉 Try Mozu Health free at mozuhealth.com — and see how AI-powered documentation can transform your ADHD therapy practice.
Your clinical expertise deserves to be paid for. Let Mozu handle the paperwork.
